The Research and Development team at CajalNeuro focuses on investigating the underlying mechanisms of neurodegenerative diseases through both experimental and computational approaches. They utilize advanced techniques in genomics, pharmacology, bioinformatics, and target validation to identify and develop potential therapeutic compounds. This multidisciplinary team works collaboratively to translate scientific discoveries into viable drug candidates, ultimately aiming to improve treatments for neurodegenerative conditions.
Adebola Enikanolaiye
Scientist
Alex Vaughan
Scientific Co-Founder
Anatoly Buchin
Senior Scientist
Anna Minkina
Scientist II
Arvis Sulovari, Ph.D...
Principal Scientist
Drew Friedmann
Senior Scientist
Ignas Cerniauskas
Scientist Ii, Pharmacology
Jennifer Whitesell
Director - Translational Model...
Johnny Goforth
Research Associate Iii, Target...
Karla Hirokawa
Scientist
View all